Kaléo Announces ALLERJECT® (epinephrine injection, USP) Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis Starting May 19, 2020

RICHMOND, VA, May 12, 2020 /CNW/ - Kaléo, a privately held U.S. pharmaceutical company, today announced that ALLERJECT® (epinephrine injection, USP), will be widely available in pharmacies across Canada beginning May 19, 2020. People interested in obtaining ALLERJECT should speak to their healthcare provider and are encouraged to check with their local pharmacy for additional availability details.